A detailed history of Black Rock Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,325,385 shares of HRTX stock, worth $13.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,325,385
Previous 7,286,028 14.27%
Holding current value
$13.3 Million
Previous $20.2 Million 44.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.32 - $3.86 $2.41 Million - $4.01 Million
1,039,357 Added 14.27%
8,325,385 $29.1 Million
Q1 2024

May 10, 2024

BUY
$1.71 - $3.06 $211,485 - $378,448
123,676 Added 1.73%
7,286,028 $20.2 Million
Q4 2023

Feb 13, 2024

SELL
$0.54 - $1.82 $520,828 - $1.76 Million
-964,497 Reduced 11.87%
7,162,352 $12.2 Million
Q3 2023

Nov 13, 2023

SELL
$0.97 - $1.8 $242,227 - $449,494
-249,719 Reduced 2.98%
8,126,849 $8.37 Million
Q2 2023

Aug 11, 2023

SELL
$1.11 - $2.88 $1.14 Million - $2.95 Million
-1,024,516 Reduced 10.9%
8,376,568 $9.72 Million
Q1 2023

May 12, 2023

SELL
$1.51 - $3.25 $376,933 - $811,281
-249,625 Reduced 2.59%
9,401,084 $14.2 Million
Q4 2022

Feb 13, 2023

BUY
$2.25 - $4.67 $882,913 - $1.83 Million
392,406 Added 4.24%
9,650,709 $24.1 Million
Q3 2022

Nov 14, 2022

BUY
$2.66 - $5.37 $1.23 Million - $2.48 Million
462,403 Added 5.26%
9,258,303 $39.1 Million
Q2 2022

Aug 12, 2022

BUY
$2.3 - $6.29 $1.47 Million - $4.02 Million
639,769 Added 7.84%
8,795,900 $24.5 Million
Q1 2022

May 12, 2022

BUY
$4.63 - $9.94 $2.19 Million - $4.71 Million
473,930 Added 6.17%
8,156,131 $46.7 Million
Q4 2021

Feb 10, 2022

BUY
$8.35 - $12.6 $77,930 - $117,595
9,333 Added 0.12%
7,682,201 $70.1 Million
Q3 2021

Nov 09, 2021

BUY
$10.13 - $15.0 $1.53 Million - $2.27 Million
151,019 Added 2.01%
7,672,868 $82 Million
Q2 2021

Aug 11, 2021

BUY
$13.27 - $18.48 $99.8 Million - $139 Million
7,521,849 New
7,521,849 $117 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $190M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.